First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 6.04 USD 2.9% Market Closed
Updated: May 11, 2024

Yield10 Bioscience Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yield10 Bioscience Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
NASDAQ:YTEN
Net Income
-$14.5m
CAGR 3-Years
-12%
CAGR 5-Years
-10%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Net Income
$4.9B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$3.8B
CAGR 3-Years
-19%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$3.9B
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
26%

See Also

What is Yield10 Bioscience Inc's Net Income?
Net Income
-14.5m USD

Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Net Income amounts to -14.5m USD.

What is Yield10 Bioscience Inc's Net Income growth rate?
Net Income CAGR 10Y
7%

Over the last year, the Net Income growth was -7%. The average annual Net Income growth rates for Yield10 Bioscience Inc have been -12% over the past three years , -10% over the past five years , and 7% over the past ten years .